Investments and investor services
Scancell Holdings soars after "stunning endorsement" of its ImmunoBody platform
Cancer Research UK was immensely impressed with the company and its technology
Company
ReNeuron Group PLC
LON:RENE
ReNeuron Group PLC has developed a proprietary stem cell-derived, exosome-based, drug delivery platform with customisable cellular targeting capabilities for the delivery of complex drug modalities. Through the generation of several unique and scalable exosome producer cell lines, its CustomEX ™ platform can be optimised for specific tissues targets and payloads leading to improvements in therapeutic outcome and a reduction in off-target effects. ReNeuron offers a delivery mechanism for a variety of payloads such as siRNA, mRNA, proteins, small molecules and genes.
298 stories · page 10 of 15
ReNeuron receives approval from US authorities to kick off phase IIb stroke trial
Long-term data from the PISCES II trial earlier this year showed ReNeuron’s CTX cell therapy candidate has the potential to improve the disability of stroke patients
Investments and investor services
FTSE 100 finishes in the red as BoE keeps rates on hold
FTSE 100 closed down over 48 points at 7,448., while FTSE 250 shed over 55 to 20,006
Investments and investor services
Will Sports Direct International investors still be optimistic when interims come out on Thursday?
Sports Direct International, Ocado Group, PZ Cussons, and Bunzl are among the names in Thursday's agenda.
Archive
Proactive news snapshot: ANGLE, ReNeuron Group, Touchstone Exploration …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Federal Reserve Grinch to dominate among upcoming central bank rate decisions
The Week Ahead will be dominated by interest rate decisions from the US Federal Reserve, Bank of England and ECB, plus UK inflation and results from Ashtead Group, TUI, and Dixons Caphone among others
Dunlelm Group plc shares boosted by pre-Christmas note from Deutsche
Vela Technologies was a big riser in early deals in London
ReNeuron establishes Boston office ahead of US clinical trials
It will be a base for medical and scientific communications staff
Archive
Proactive news snapshot: Victoria Oil & Gas, Shanta Gold, Belvoir Lettings,Cabot Energy
A look at some of the day's highlights from the Proactive Investors newswire
ReNeuron jumps at opening bell as it gets green light to begin second part of phase I/II eye disease trial
Data from the phase II part of the phase I/II trial is expected in the second half of 2018, with readouts from the subsequent, larger phase IIb study due in 2020
ReNeuron making good progress with all of its key therapeutic programmes
As of March, ReNeuron had £53mln in cash equivalents but its market value is not too much above that....
Archive
Proactive news snapshot: Wolf Minerals , Sareum Holdings, ReNeuron Group …
A glance at some of the day's highlights from the Proactive Investors newswire
Metminco rallies on quarterly update, Pantheon Resources shares fall on drilling difficulties
A look at some of the biggest risers and fallers in London today
ReNeuron boss “delighted” with long-term stroke data
“These positive long term results are highly encouraging, indicating that the CTX therapy has the potential to produce meaningful and sustained improvements in disability as well as motor function in disabled stroke patients”
FTSE 100 closes a shade higher as pound strengthens ahead of rate decision
Around 4pm, the UK blue chip index rose 2 points to 7,490
Archive
Proactive news snapshot: Kibo Mining, Symphony Environmental Technologies, ReNeuron …
A glance at some of the day's highlights from the Proactive Investors newswire
ReNeuron awarded new grant by Wales for exosome research
The grant, awarded under the SMARTExpertise scheme, will help fund a £1.2m collaborative programme of work
FTSE 100 ends the week on a firm note
The blue-chip index finished the day above the 7,500 level
Archive
Proactive news snapshot: Jersey Oil and Gas, Landore Resources, Columbus Energy Resources …
A glance at some of the day's highlights from the Proactive Investors newswire